[1] |
Global Initiative for Ashma. Global strategy for asthma management and prevention(2021 update)[EB/OL]. [2022-02-15].
|
[2] |
HUANG K W, YANG T, XU J Y,et al. Prevalence,risk factors,and management of asthma in China:a national cross-sectional study[J]. Lancet, 2019, 394(10196):407-418. DOI: 10.1016/S0140-6736(19)31147-X.
|
[3] |
|
[4] |
Global Initiative for Asthma. Global strategy for asthma management and prevention(2021 update)[EB/OL]. [2022-02-15].
|
[5] |
|
[6] |
|
[7] |
JUNIPER E F, O'BYRNE P M, GUYATT G H,et al. Development and validation of a questionnaire to measure asthma control[J]. Eur Respir J, 1999, 14(4):902-907. DOI: 10.1034/j.1399-3003.1999.14d29.x.
|
[8] |
|
[9] |
MA W, YU L, WANG Y,et al. Changes in health-related quality of life and clinical implications in Chinese patients with chronic cough[J]. Cough, 2009, 5:7. DOI: 10.1186/1745-9974-5-7.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
HEKKING P P, BEL E H. Developing and emerging clinical asthma phenotypes[J]. J Allergy Clin Immunol Pract, 2014, 2(6):671-680;quiz 681. DOI: 10.1016/j.jaip.2014.09.007.
|
[16] |
|
[17] |
SCHLEICHF N, MANISE M, SELE J,et al. Distribution of sputum cellular phenotype in a large asthma cohort:predicting factors for eosinophilic vs neutrophilic inflammation[J]. BMC Pulm Med, 2013, 13:11. DOI: 10.1186/1471-2466-13-11.
|
[18] |
|
[19] |
MCGRATH K W, ICITOVIC N, BOUSHEY H A,et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic[J]. Am J Respir Crit Care Med, 2012, 185(6):612-619. DOI: 10.1164/rccm.201109-1640OC.
|
[20] |
|
[21] |
COMPALATI E, RIDOLO E, PASSALACQUA G,et al. The link between allergic rhinitis and asthma:the united airways disease[J]. Expert Rev Clin Immunol, 2010, 6(3):413-423. DOI: 10.1586/eci.10.15.
|
[22] |
MORJARIA J B, CARUSO M, EMMA R,et al. Treatment of allergic rhinitis as a strategy for preventing asthma[J]. Curr Allergy Asthma Rep, 2018, 18(4):23. DOI: 10.1007/s11882-018-0781-y.
|
[23] |
林月娇. 不同表型哮喘患者上、下气道炎症特征及一致性研究[D]. 广州:广州医科大学,2019.
|
[24] |
|
[25] |
DWEIK R A, BOGGS P B, ERZURUM S C,et al. An official ATS clinical practice guideline:interpretation of exhaled nitric oxide levels (FENO) for clinical applications[J]. Am J Respir Crit Care Med, 2011, 184(5):602-615. DOI: 10.1164/rccm.9120-11ST.
|
[26] |
|
[27] |
|
[28] |
GAO S J, GE Y P, ZHANG C J. Correlation between fractional exhaled nitric oxide levels and efficacy of inhaled corticosteroids in children with bronchial asthma[J]. Am J Ther, 2018, 25(6):e617-625. DOI: 10.1097/MJT.0000000000000423.
|
[29] |
|
[30] |
|
[31] |
|
[32] |
彭锦芸. 闽东地区不同人群成人支气管哮喘患者呼出气一氧化氮水平与炎症表型的相关性研究[D]. 福州:福建医科大学,2017.
|
[33] |
赵雪. 哮喘患者呼出气一氧化氮水平与不同气道炎症表型相关性研究[D]. 石家庄:河北医科大学,2019.
|
[34] |
|
[35] |
刘奕. 不同炎症表型支气管哮喘FeNO检测的临床价值研究[D]. 吉首:吉首大学,2020.
|
[36] |
GAO W, HANG J, ZHUY J,et al. Clinical characteristics and biomarkers analysis of asthma inflammatory phenotypes[J]. Biomark Med, 2020, 14(3):211-222. DOI: 10.2217/bmm-2019-0487.
|
[37] |
DONATH H, KLUGE S, SIDERI G,et al. Hospitalization,asthma phenotypes,and readmission rates in pre-school asthma[J]. Front Pediatr, 2020, 8:562843. DOI: 10.3389/fped.2020.562843.
|
[38] |
|
[39] |
|
[40] |
|
[41] |
WARK P A, JOHNSTON S L, MORIC I,et al. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma[J]. Eur Respir J, 2002, 19(1):68-75. DOI: 10.1183/09031936.02.00226302.
|
[42] |
|